The exploration and practice of new management mode of long-term medication safety assessment for bronchial asthma patients with the participation of pharmacists team in medical treatment combination

Nan ZHANG,Kuo YAN,Hong-liu LU,Xiu-ling LU,Xiu-mei YOU,Hui-juan YANG,Bing XUE,Wen-bin XIA
DOI: https://doi.org/10.3969/j.issn.1672-3384.2017.12.003
2017-01-01
Abstract:Objective: To explore the management mode of long-term medication safety assessment for bronchial asthma patients with the participation of pharmacists team in medical treatment combination, and to provide references for pharmacists to participate in the management of chronic disease under the new situation of new medical reform. Methods: 133 patients with asthma matched with the inclusion criteria in our hospital and medical treatment combination were selected. These patients receive medication use management including drug safety comprehensive evaluation, classification management, follow-up with medication guidance, integrated prescriptions checking and building shared database with the participation led by our clinical pharmacist to guide the community pharmacists. Results: After a year of the management mode practice, the patient safety medication cognitive ability and medication adherence significantly increased (P < 0.05), patients with asthma disease control situation (ACT score) improved significantly (P < 0.01), the effective identification and intervention irrational prescription capacity significantly increased (P < 0.01). Conclusion: The management mode of long-term medication safety assessment for asthma patients with the participation of pharmacist team in medical treatment combination has significant effects on asthma patients' safety medication and drug treatment effect, and improving the professional service of pharmacist team.
What problem does this paper attempt to address?